Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS) | Zendy

Kaitlin E. Kennedy | Zendy; Chengwen Teng | Zendy; Taylor M. Patek | Zendy; Christopher R. Frei | Zendy

Open Access

Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)

Author(s) -

Kaitlin E. Kennedy,

Chengwen Teng,

Taylor M. Patek,

Christopher R. Frei

Publication year - 2019

Publication title -

drug safety

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.377

H-Index - 124

eISSN - 1179-1942

pISSN - 0114-5916

DOI - 10.1007/s40264-019-00901-7

Subject(s) - medicine , adverse event reporting system , hypoglycemia , tigecycline , ertapenem , moxifloxacin , adverse effect , linezolid , concomitant , odds ratio , antibiotics , pharmacology , vancomycin , antibiotic resistance , microbiology and biotechnology , insulin , imipenem , genetics , bacteria , biology , staphylococcus aureus

Fluoroquinolones, clarithromycin, linezolid, tigecycline, cefditoren, doxycycline, and trimethoprim-sulfamethoxazole are known to be associated with hypoglycemia, but few studies have considered concomitant glucose-lowering medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research